MPO and diabetes mellitus: Furthermore, DM patient plasma myeloperoxidase (MPO) concentrations were significantly higher than for controls (Figure 1C; 4.3 ± 1.0 ng/mL vs 2.5 ± 0.6 ng/mL, p < 0.001).